Respiri chooses Entech as global manufacturing partner

Medical technology company Respiri has chosen Adelaide’s Entech Electronics as its global manufacturing partner for its Wheezo devices to monitor wheezing and breathing in asthma sufferers. The device is the world’s first digital wheeze monitoring solution of sensor, smartphone application and digital health platform to help people manage respiratory disease. Wheezo has TGA and CE…

Wheezo from Respiri set to go on sale.

Respiri Limited (ASX:RSH) has achieved TGA approval to list its wheezo asthma monitoring device (pictured) on the Australian Therapeutics Goods Register (ARTG). The device is the world’s first digital wheeze monitoring solution of sensor, smartphone application and digital health platform to help people manage respiratory disease. TGA approval came after the Melbourne company undertook an…

Manufacturing news briefs – stories you might have missed

Industry plan offers guidance for business Small businesses are being given more help and guidance with the release of the government’s third Sovereign Industrial Capability Priority Implementation Plan. Minister for defence industry, Melissa Price today announced the Land Combat and Protected Vehicles and Technology Upgrades Plan. The Plan provides useful information to businesses who already…

Monday news briefs – stories you might have missed

Respiri secures global sales and distribution agreement Asthma management system developer Respiri has signed an exclusive agreement with pharmaceutical firm Cipla to sell its Wheezo asthma management device. Cipla will initially market Wheezo in Australia and New Zealand, with further territories including the United States, Europe and India also on Cipla’s radar. Initial minimum sales…